This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
large-cap: Archive
3 Medical Stocks to Consider as Markets Take a Breather
by Shaun Pruitt
These top medical stocks may be able to provide defensive safety after President Trump's tariff hikes and July's unfavorable jobs report led to a market selloff.
JNJNegative Net Change THCPositive Net Change CVSPositive Net Change
dividend-investing dividends earnings hospitals immuno-therapy investing large-cap medical oncology-screening pharmaceuticals
Is Microsoft (MSFT) a 'Buy' Ahead of Upcoming Earnings Announcement?
by Bryan Hayes
Adding to investor confidence is Microsoft's impressive track record of beating expectations. The tech giant has exceeded earnings estimates for 11 consecutive quarters.
MSFTNegative Net Change
artificial-intelligence cloud-computing computers cybersecurity dividend-investing earnings investing large-cap magnificent-7 software stock-performance tech-stocks
Bull of the Day: Amazon (AMZN)
by Shaun Pruitt
With AI starting to streamline its businesses, Amazon stock looks poised to keep soaring after rebounding more than +20% in the last three months.
AMZNNegative Net Change MSFTNegative Net Change GOOGLNegative Net Change METANegative Net Change
ad-tech artificial-intelligence cloud-computing earnings internet investing large-cap magnificent-7 tech-stocks
Is American Airlines Stock Too Cheap to Ignore After Beating Q2 Expectations?
by Shaun Pruitt
American Airlines (AAL) stock was down as much as 10% in Thursday morning's trading session despite pleasantly exceeding Q2 top and bottom-line expectations.
AALNegative Net Change DALNegative Net Change UALNegative Net Change
airlines earnings investing large-cap transportation
Should Investors Buy Capital One Stock After Crushing Q2 EPS Expectations?
by Shaun Pruitt
While Capital One wasn't able to raise its full-year guidance after crushing Q2 EPS expectations, reconfirming its outlook was still a meaningful sign that the acquisition of Discover Financial Services is paying off.
COFPositive Net Change MAPositive Net Change VNegative Net Change TSLAPositive Net Change GOOGLNegative Net Change
earnings finance investing large-cap payments
Bull of the Day: Meta Platforms (META)
by Shaun Pruitt
Set to report its quarterly results on Wednesday, July 30, Meta Platforms' AI infrastructure expansion could make its stock the highlight of the Q2 earnings season.
METANegative Net Change TSLAPositive Net Change GOOGLNegative Net Change
ad-tech advertising artificial-intelligence earnings internet investing large-cap magnificent-7 social-media tech-stocks
Will Alphabet's Stock Keep Rebounding as Q2 Earnings Approach?
by Shaun Pruitt
Rebounding and soaring over +20% in the last three months, Alphabet stock is now virtually flat in 2025 with the tech giant's much-anticipated Q2 results approaching on Wednesday, July 23.
GOOGLNegative Net Change AMZNNegative Net Change MSFTNegative Net Change METANegative Net Change
artificial-intelligence cloud-computing earnings large-cap magnificent-7 tech-stocks
Buy, Hold, or Take Profits in Netflix Stock After Q2 Earnings?
by Shaun Pruitt
Investors appear to be a bit underwhelmed by Netflix's (NFLX) Q2 report, despite the streaming king posting favorable quarterly results after market hours on Thursday.
NFLXNegative Net Change AMZNNegative Net Change DISPositive Net Change PARANo Net Change
consumer-discretionary earnings investing large-cap
State Street Vs BlackRock: Which Finance Stock is the Better Buy After Q2 Earnings?
by Shaun Pruitt
Able to exceed their Q2 earnings expectations on Tuesday, investors may be wondering which of these renowned asset managers is the better investment at the moment.
BLKNegative Net Change STTPositive Net Change
dividend-investing dividends earnings etfs finance investing large-cap
3 Medical Stocks to Watch as Q2 Earnings Approach: ABT, JNJ, NVS
by Shaun Pruitt
The broader market's historic rebound may make it necessary to consider some defensive positions in the portfolio, and these medical stocks fit the bill ahead of their Q2 reports.
ABTNegative Net Change NVSNegative Net Change JNJNegative Net Change
dividend-investing dividends earnings inflation investing large-cap medical medical-devices pharmaceuticals